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ABSTRACT
Introduction: Recto-vaginal endometriosis surgical management needing partial colpectomy is a 
surgically challenging condition and has been associated with a notable risk of major 
postoperative complications. In the present study we sought to compare feasibility and safety of 
total laparoscopic (TL) and vaginal-assisted (VA) routes in women affected by symptomatic recto-
vaginal endometriosis with vaginal mucosa infiltration scheduled for minimally invasive surgery. 
Material and methods: Multi-centric, retrospective cohort study on medical records of 
consecutive reproductive age women submitted to complete macroscopic eradication of 
symptomatic recto-vaginal endometriosis with vaginal mucosa infiltration between March 2013 
and November 2017. The two groups were compared in terms of preoperative data and surgical 
outcomes. Results: 84 women were included in the study (TL=57 and VA=27). The two groups 
were comparable in terms of preoperative, surgical and postoperative data. The major 
postoperative complications rate was 5.3% (three out of 57) in TL group and 7.4% (two out of 27) 
in VA group, without a significant difference. In the TL group we reported one case of bowel 
anastomosis dehiscence and two cases of pelvic abscess; in the VA group, one case of small bowel 
perforation after extensive adhesiolysis treated with ileal resection and one case of rectal sub-
occlusion after segmental resection and mechanical anastomosis were noticed. Conclusions: In 
women affected by recto-vaginal endometriosis with vaginal mucosal infiltration, perioperative 
outcomes seem not to be influenced by the surgical route adopted.
Keywords
rectovaginal endometriosis; laparoscopic route; vaginal-assisted route; minimally invasive 
surgery; endometriosis surgical treatment; usability
Abbreviations
RVE: recto-vaginal endometriosisA
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TL: total laparoscopic 
VA: vaginal-assisted
Key Message:
Comparison in terms of safety and feasibility of total laparoscopic and vaginal-assisted 
laparoscopic approach for recto-vaginal endometriosis treatment.
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INTRODUCTION
Endometriosis is defined as the presence of endometrial tissue outside the uterine cavity (1). It 
represents an important cause of morbidity in reproductive-aged women resulting in pelvic pain, 
pelvic masses and infertility (2;3). The most severe form of the disease is represented by deep 
infiltrating endometriosis, defined as endometriotic lesions infiltrating pelvic organ wall or 
retroperitoneal structures (4). Deep lesions are typically multifocal, involving most commonly 
uterosacral ligaments, upper third of posterior vaginal wall, bowel, bladder and ureters (4-6).
Vaginal endometriosis is defined as infiltration of vaginal wall by the disease. It can be isolated or 
more commonly associated with an adjacent posterior nodule in the recto-vaginal space and in 
some cases on the anterior surface of the recto-sigmoid tract (recto-vaginal endometriosis (RVE)) 
(4;7).  RVE incidence is estimated from 3.8% to 37% among women with endometriosis (8;9). 
Vaginal lesions are characterized by visible red, blue, or hemorrhagic nodules at speculum 
examination or tender nodules and fibrosis at palpation of the upper third of vagina (10). 
Hormonal therapy improves pain symptoms in around two-thirds of women with RVE (7). 
However, surgical excision of endometriosis is required in case of pain symptoms resistant to 
hormonal therapy, complicated disease (bowel or urinary obstruction) or infertility after several 
assisted reproductive technology cycles. (6;11). Noteworthy, RVE surgical management needing 
partial colpectomy is a surgically challenging condition and has been associated with a notable 
risk of major postoperative complications, especially urinary (12) and colorectal ones (13). 
RVE with vaginal mucosa infiltration can be isolated and excised using total laparoscopic (TL) or 
vaginal-assisted laparoscopic route (VA) (8;13-18). Although laparoscopy represents the gold 
standard for endometriosis treatment, there is no strong evidence to support the best approach in 
case of RVE.
In the present study, we sought to compare feasibility and safety of the TL and VA routes in 
women affected by symptomatic RVE with vaginal mucosa infiltration scheduled for minimally 
invasive surgery.
MATERIAL AND METHODSA
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Study design 
The present study is a multi-centric, retrospective cohort study. Medical records of consecutive 
reproductive age women submitted to complete macroscopic eradication for symptomatic RVE 
with vaginal mucosa infiltration between March 2013 and November 2017 were reviewed.
The population included women referring to Department of Gynecology at S.Orsola Academic 
Hospital in Bologna, Fondazione di Ricerca e Cura Giovanni Paolo II in Campobasso and 
Fondazione Policlinico Universitario A. Gemelli IRCCS in Rome. 
Exclusion criteria were: women < 18 years and > 50 years; history of RVE surgical treatment or 
hysterectomy; previous or ongoing gynecological neoplastic pathology.
Before surgery, women demographic features and pain symptoms (chronic pelvic pain, 
dysmenorrhea, dyspareunia, dysuria, dyschezia) were assessed. Pain intensity was evaluated using 
a 10-cm visual analogue scale (VAS). 
All women underwent bimanual and speculum examinations as well as transvaginal and 
transabdominal ultrasonography performed by skilled operators. When necessary, additional 
preoperative imaging methods, including multidetector computerized tomography enteroclysis 
urography or magnetic resonance imaging, were performed to plan surgery (19).
In all centers, women were followed up 30 days after surgery in order to evaluate their general 
health condition, post-operative pain scores and complications. 
Surgical procedure
Women under general anaesthesia were placed in a low dorsal-lithotomy position and a speculum 
examination was performed in order to identify any vaginal lesions. Adhesiolysis, excision of 
endometriotic peritoneal implants, ovarian cystectomy and temporary ovarian suspension, when 
needed, were all performed prior to deep endometriotic nodule removal, as previously published 
(20-21). The pelvis was examined to verify the presence of deep infiltrating endometriosis with 
bowel, urinary bladder, utero-sacral ligaments, parametrial or ureteral involvement. Recto-sigmoid 
endometriosis was removed using a conservative (shaving) or radical (segmental or discoid A
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resection) approach, as previously published (22). All patients were informed and counseled 
regarding the risk of bowel resection and the final decision made at time of surgery according to 
the depth of bowel involvement at macroscopic evaluation. Resections were classified as 
high/medium (>8 cm), low (5–8 cm), or ultralow (<5cm), according to distance from the anus. 
When the risk of major rectal complications was present according to intraoperative findings (i.e. 
low rectal resection associated to posterior colpotomy), a protective ileostomy was considered.
Bladder endometriosis was removed through a partial cystectomy with or without opening of the 
urinary bladder lumen. As previously stated (23;24), in case of ureteral involvement by 
endometriosis or surrounding fibrosis, conservative or radical procedures were performed.
All specimens were sent for routine histological examination. Endometriosis was considered 
histologically confirmed when endometrial glands and stroma were found in the examined 
specimens. 
All surgical procedures were carried out by three surgeons (R.S., M.M., F.C.) with extensive 
experience on both techniques for the surgical treatment of RVE. Endometriosis severity was 
defined using the intraoperative classification revised by the American Society for Reproductive 
Medicine (rASRM) (25).
Total-laparoscopic route
Total laparoscopic (TL) consisted of complete removal of the RVE nodule, with or without bowel 
involvement, through laparoscopic approach (Figure 1). After development of pararectal and 
rectovaginal spaces, the RVE nodule was freed from any adhesions with the uterine cervix and 
isolated from the adjacent healthy tissue of the vaginal fornix through colpotomy. A pad of gauze 
wrapped in a surgical glove was placed inside the vagina to prevent loss of the pneumoperitoneum 
during the vaginal incision. After visual confirmation of vaginal free margins, the vaginal wall 
defect was closed laparoscopically or vaginally by interrupted or running sutures. In case of bowel 
involvement, the nodule left attached to the rectum was removed en-bloc through bowel segmental 
resection or conservative procedures, using the reverse technique according to Kondo et al. (13).
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Vaginal-assisted route
The vaginal-assisted route (VA) consisted of the incision and isolation of the affected vaginal area 
through vaginal approach before laparoscopic entry (Figure 2) (14). In particular, vaginal fornices 
were exposed by two Breisky specula and the cervix was pulled ventrally by two tenacula. The 
vaginal wall was cut around the endometriotic nodule with disease free margins through the 
vaginal route. Then the vaginal nodule was isolated and pushed dorsally, in order to be 
subsequently removed together with the rectovaginal lesion through the laparoscopic route. The 
vaginal wall defect was closed vaginally by interrupted sutures.
The study population was divided into two groups, according to surgical approach used to isolate 
and remove RVE nodule: TL vs VA route. Preoperative, surgical and postoperative data were 
compared between the two groups. In particular, surgical outcomes included association with other 
endometriotic lesions, operative time, estimated blood loss, hospital stay, laparotomic conversion 
rate, number and type of associated surgical procedures and complication rate within 30 days from 
surgery. The evaluation of complications rate was carried out using the Clavien-Dindo 
Classification (26).
Statistical analyses
Continuous data were expressed as mean ± standard deviation (SD) or as median (range). 
Categorical variables were expressed as absolute number and percentages. Univariate comparisons 
of continuous data were conducted with a 2-sample t test or the Mann-Whitney test for continuous 
data and a chi-square test or Fisher’s exact test for categorical data, respectively. All reported P 
values were 2-sided, and a P value of less than .05 denoted a significant difference. Statistical 
analysis was carried out using the Statistical Package for the Social Sciences (SPSS) software 
version 24.0 (IBM Corp., Armonk, NY, USA).
Ethical approval
The study was approved by the local Ethical Committees (CICOG-31-10-18/180 approved  on 
31/10/2018)  and registered on ClinicalTrial.gov with the following ID number: NCT03744143.A
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RESULTS
Eighty-four women meeting the inclusion and exclusion criteria were evaluated for study analysis. 
During preoperative diagnostic work-up, multidetector computerized tomography enteroclysis 
urography and magnetic resonance imaging were performed in  24 (28.6%) and 46 (54.8%) 
patients, respectively. In all cases, vaginal nodule involved the posterior fornix; while lateral 
vaginal infiltration was observed in 29 (29/84, 34.5%) women. We noticed a significant difference 
in terms of lateral vaginal infiltration between the two groups [24/52 (46.1%) in TL group vs 5/27 
(18.5%) in VA group, p=0.03]. Women were divided into two groups: in 57 (67.9%) of them the 
RVS nodule was removed using TL, while in the remaining 27 (32.1%) the VA approach was 
performed. The two groups were comparable in terms of demographic and preoperative clinical 
data (Table 1). 
Surgical details are reported in Table 2. The two groups were similar in terms of operative time, 
estimated blood loss, and concomitant procedures. In only one case laparotomic conversion was 
needed due to severe adhesion syndrome. In the TL group, 46 women (81%) presented recto-
sigmoid endometriosis. Out of them, 24 (52.2%) underwent segmental bowel resection, three 
(6.5%) underwent discoid resection and 19 (41.3%) shaving technique. Conversely, in the VA 
group, 20 (74.1%) women had bowel endometriosis requiring in 7 (35%) cases segmental bowel 
resection and in 13 (65%) shaving technique. There was no statistically significant difference 
between TL and VA groups concerning bowel surgical procedures adopted. 
In all women submitted to VA approach, the vaginal wall defect was routinely closed through 
vaginal route. Instead, after TL approach, the vaginal wall defect was closed laparoscopically and 
vaginally in 26 (45.6%) and 31 (54.4%), respectively. In our vision, vaginal route for 
colporrhaphy was preferred in case of segmental or discoid resection or deep shaving with 
reinforcing sutures in order to avoid juxtaposition of the vaginal and rectal sutures.
Pathological examinations confirmed endometriosis in all women.
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Postoperative data are shown in Table 3. In both groups pain symptoms’ severity significantly 
decreased at one month follow-up. The two groups were comparable for length of hospitalization 
and postoperative complications. The major postoperative complications rate between TL and VA 
groups was similar: 5.3% (three out of 57 women) vs 7.4% (two out of 27 women), respectively. 
In TL group we reported one case of bowel anastomosis dehiscence and two cases of pelvic 
abscess; in VA group, one case of small bowel perforation after extensive adhesiolysis treated 
with ileal resection and one case of rectal sub-occlusion after segmental resection and mechanical 
anastomosis were noticed.  
DISCUSSION
In the present study, we observed no significant difference in terms of safety and feasibility 
between TL and VA routes for the surgical treatment of symptomatic RVE involving the posterior 
vaginal mucosa.
Up to date, several retrospective studies evaluated surgical outcomes in women treated for RVE 
involving vaginal mucosa with or without rectal involvement using a preferred technique (13-17). 
Chapron et al (15) described 29 women undergoing RVE plus rectal nodule removal using VA 
laparoscopic route. In particular, they started with laparoscopic route and isolated the RVE nodule 
from the anterior rectal wall through shaving procedure, leaving it attached to the posterior vaginal 
fornix (standard or traditional technique). Vaginal colpectomy was then performed including 
healthy vaginal tissue around the endometriotic nodule. No conversion occurred and they observed 
only one case (3.5%) of postoperative rectovaginal fistula. 
Kondo et al (13) evaluated 75 women affected by RVE with bowel involvement and compared, in 
these women, surgical outcomes of standard and reverse laparoscopic techniques (35 and 40 
women, respectively). During the reverse technique, after isolation of RVE nodule through 
colpectomy, the posterior nodule attached to the rectum was displaced cranially and removed 
through colorectal resection or shaving procedure.  Authors concluded that the two approaches 
were similar in terms of operative time, blood loss, laparotomic conversion rate, major 
intraoperative complications, length of hospitalization, and minor post-operative complications. 
However, the major post-operative complications rate was significantly higher adopting standard A
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rather than reverse technique (22.9% vs 5% respectively, p=0.002). Furthermore, they noted a 
restricted range of movements and working space using standard technique.
Possover et al (14) analyzed a group of 34 women undergoing RVE plus rectal nodule removal 
through VA laparoscopy using reverse technique. In all cases bowel segmental resection was 
performed. No laparotomic conversion neither major intraoperative complications occurred. Only 
two women suffered minor anastomotic leakage (5.8%), detected by sigmoidoscopy and healed 
spontaneously. 
Zanetti-Dallenbach et al. (9) were the first to compare, in terms of surgical data, total 
abdominal/laparoscopic (18 patients) and VA routes (30 women) for RVE plus rectal nodule 
removal. In all cases the affected bowel was excised using segmental resection.  Authors 
concluded that the combined approach significantly reduced complication rate (10% vs 38.9% 
respectively, p=0.03), hospitalization time in days (13.7± 2.7 vs 15.8 ± 3.6, respectively, p=0.02) 
and re-hospitalization rate (0 vs 22.2%, p=0.02). Conversely, in our study we did not find these 
statistical differences between TL and VA approaches. These different findings can be explained 
by the inclusion of women scheduled only for laparoscopic surgery and without constant rectal 
involvement requiring a bowel resection. 
The generalizability of results of the present study is limited by its retrospective design and 
tertiary center setting with experienced surgeons. Due to the lack of data comparing the two 
techniques for RVE eradication, in our study the choice of the approach has been essentially based 
on the surgeons' discretion and preference, case by case. We can hypothesize that lateral vaginal 
infiltration during speculum evaluation could have influenced surgical choice in favor of TL 
approach due to proximity to the ureters. However, no significant differences were reported in 
terms of associated surgical procedures and stages of disease at intraoperative evaluation.
Furthermore, being our study retrospective, it is difficult to directly link the surgical route adopted 
with iatrogenic complications. After a detailed revision of surgical charts, the surgical approach 
did not seem to be directly related to peri-operative complications detected during the study 
period, but to other surgical issues related to this complex multi-visceral surgery. 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved
In our tertiary level centers, the presence of large bowel nodules with high rate of previous 
conservative rectal surgery and the need for low rectal resections justified the great number of 
segmental resections and ileostomies performed during the study period.
On the other hand, high volume providers (tertiary hospitals and skilled surgeons) for colorectal 
surgery for endometriosis are associated to lower incidence of perioperative complications rather 
than facilities with low volume of activity (27). Feasibility and safety of posterior DIE surgery are 
strictly related to skills and experience of surgeons.
Lastly, due to limited follow-up time we could have missed delayed major complications. Future 
randomized controlled trials with long-term follow-up are needed to investigate any differences 
between the two routes for RVE surgical treatment.
CONCLUSION
In symptomatic women affected by RVE with vaginal mucosal infiltration requiring surgery, total 
laparoscopic and vaginal-assisted routes were comparable in terms of safety and feasibility.  
Women with RVE should be adequately counseled on potential complications associated with this 
challenging surgery. 
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Tables
Table 1. Preoperative data of the study groups: total-laparoscopic (TL) and vaginal-assisted (VA) 
approach.
Table 2. Surgical data of the study groups: total-laparoscopic (TL) and vaginal-assisted (VA) 
approach.
Table 3. Postoperative data of the study groups: total-laparoscopic (TL) and vaginal-assisted (VA) 
approach.
Figures
Figure 1. Total-laparoscopic approach: A. Colpotomy via laparoscopic approach; B. RVE nodule 
removal via laparoscopic route
Figure 2. Vaginal-assisted approach: A. Colpotomy via vaginal route; B. RVE nodule removal via 
laparoscopic route.
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Table 1. Preoperative data of the study groups: total-laparoscopic (TL) and vaginal-assisted 
(VA) approach 
 
 TL 
(57) 
VA 
(27) 
p value 
Age (years old), mean ± SD 36.1 ± 4.9 34.2 ± 7.2 0.1 
Body mass index (kg/m2), mean ± SD 22.4 ± 3.1 21.9 ± 3.1 0.1 
Parity >=1, n (%) 3 (5.3) 3 (11.1) 0.8 
Previous surgery for endometriosis, n (%) 22 (38.6) 12 (44.4) 0.6 
- Ovarian endometriosis 17/22 (77.3) 9/12 (75.0) 0.8 
- Deep infiltrating endometriosis 5/22 (22.7) 3/12 (25.0)  
Stage of disease according to rASRM, n (%)    
-  Stage III 10/57 (17.5) 9/27 (33.3) 0.1 
-  Stage IV 47/57 (82.5) 18/27 (66.7)  
Preoperative pain symptoms assessed with VAS, median (range)    
-  Dysmenorrhea 8 (2-10) 8 (4-10) 0.9 
-  Dyschezia 6 (2-10) 4 (2-10) 1 
-  Dysuria 0 (0-9) 0 (0-10) 0.2 
-  Dyspareunia 7 (0-10) 7 (2-10) 0.4 
-  Chronic pelvic pain 8 (1-10) 7 (1-10) 0.4 A
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Preoperative medical therapy, n (%) 46 (80.7) 18 (66.7) 0.1 
- Estro-progestinic 30/46 (65.2) 15/18 (83.3) 0.3 
- Progestinic 14/46 (30.4) 2/18 (11.1)  
- GnRH agonist  2/46 (4.3) 1/18 (5.6)  
 
n: number 
rASRM: revised American Society for Reproductive Medicine 
SD: Standard Deviation 
VAS: Visual Analogue Scale 
GnRH agonist: Gonadotropin-releasing Hormone Agonist 
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Table 2. Surgical data of the study groups: total-laparoscopic (TL) and vaginal-assisted (VA) 
approach  
 
 TL (57) VA (27) p-value 
Operative time (minutes), mean ± SD 197 ± 83.4 191.3 ± 92 0.5 
EBL (ml), mean ± SD 143.9 ± 66.2 177.8 ± 78.2 0.8 
Laparotomic conversion, n (%) 1 (1.7) 0 (0.0) 1.0 
Adenomyosis, n (%) 26 (45.6) 13 (48.1) 1.0 
Associated surgical procedures, n (%)    
- Adhesiolysis 57 (100.0) 26 (96.3) 0.1 
- Hysterectomy 2 (3.5) 0 (0.0) 1.0 
- Excision of endometrioma 25 (43.9) 12 (44.4) 0.5 
-    Monolateral 16/25 (64.0) 10/12 (83.3) 0.4 
-    Bilateral 9/25 (36.0) 2/12 (16.7)  
- Salpingectomy 13 (22.8) 6 (22.2) 0.7 
-    Monolateral 7/13 (53.8) 2/6 (33.3) 0.7 
-    Bilateral 6/13 (46.2) 4/6 (66.7)  
- Excision of peritoneal endometriosis 36 (63.2) 12 (44.4) 0.1 
- Uterosacral ligament nodule removal 32 (56.1) 10 (37.0) 0.1 
-     Monolateral 18/32 (56.3) 8/10 (80.0) 0.3 A
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-    Bilateral 14/32 (43.8) 2/10 (20.0)  
- Ureteral surgery 54 (94.7) 25(92.6) 0.9 
-    Ureterolysis 33/54 (61.1) 20/25 (80.0) 0.2 
      -Monolateral 5/33 (15.2) 2/20 (10.0) 0.9 
       -Bilateral 28/33 (84.8) 18/20 (90.0)  
-    Nodule removal 21/54 (38.9) 5/25 (20)  
      -Monolateral 19/21 (90.5) 5/5 (100.0) 1.0 
      -Bilateral 2/21 (9.5) 0 (0.0)  
- Recto-sigmoid nodule removal 46 (80.7) 20 (74.1) 0.4 
-  Shaving 19/46 (41.3) 13/20 (65.0) 0.2 
-  Discoid resection 3/46 (6.5) 0 (0.0)  
-  Segmental resection 24/46 (52.2) 7/20 (35.0)  
        - high/medium 17/24 (70.8) 5/7 (71.4) 1.0 
        -low/ultra-low 7/24 (29.2) 2/7 (28.6)  
       -     Ileo-cecal resection  1 (1.8) 0 (0.0) 1.0 
- Ileostomy 9 (15.8) 3 (11.1) 0.7 
- Omental flap 2 (3.5) 0 (0.0) 1.3 
- Partial cystectomy for urinary 
bladder nodule 
8 (14.0) 3 (11.1) 0.7 
-    with opening of the urinary 3/8 (37.5) 1/3 (33.3) 0.6 A
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bladder lumen 
-    without opening of the urinary 
bladder lumen 
5/8 (62.5) 2/3 (66.7)  
- Lateral parametrial nodule 26 (45.6) 8 (29.6) 0.9 
-    Monolateral 26/26 (100.0) 7/8 (87.5) 0.2 
-    Bilateral 0 (0.0) 1/8 (12.5)  
Maximum size of vaginal nodule (cm), mean 
± SD 
2 ± 0.6 2.1 ± 0.9 0.5 
Maximum size of posterior deep nodule 
(cm), mean ± SD 
4.1 ± 0.7 4.5 ± 0.8 0.2 
 
Legend: 
n: number 
EBL: Estimated Blood Loss 
SD: Standard Deviation 
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Table 3. Postoperative data of the study groups: total-laparoscopic (TL) and vaginal-assisted 
(VA) approach 
 
 TL (57) VA (27) p-
value 
Hospital stay (days), mean ± SD 7.2 ± 3.6 6.9 ± 3.1 0.4 
Complications (Clavien-Dindo classification), n (%) 9 (15.8) 5 (18.5) 0.8 
-    Grade I 3/9 (33.3) 2/5 (40.0) 0.9 
-    Grade II 3/9 (33.3) 1/5 (20.0)  
-    Grade IIIa 0 (0.0) 0 (0.0)  
-    Grade IIIb 3/9 (33.3) 2/5 (40.0)  
Pain symptoms assessed with VAS at 1-month follow-up, 
median (range) 
   
-  Dysmenorrhea       0 (0-9) 0 (0-8) 0.9 
-  Dyschezia 0 (0-9) 0 (0-8) 0.9 
-  Dysuria       0 (0-2) 0 (0-4) 0.6 
-  Chronic pelvic pain        0 (0-7)  0 (0-7) 0.9 
 
Legend: 
n: number 
SD: Standard Deviation 
VAS: Visual Analogue Scale A
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